These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Animal models in experimental atherosclerosis: a critical review. Fekete S Acta Vet Hung; 1993; 41(1-2):3-9. PubMed ID: 8116498 [TBL] [Abstract][Full Text] [Related]
3. Risk factors in the pathogenesis of atherosclerotic heart disease and generalized atherosclerosis. Taylor CB; Hass GM; Ho KJ; Liu LB Ann Clin Lab Sci (1971); 1972; 2(3):239-43. PubMed ID: 4628363 [No Abstract] [Full Text] [Related]
4. [The vasoactive properties of different classes of blood lipoproteins in hypercholesterolemia and atherosclerosis]. Frol'kis VV; Kul'chitskiĭ OK; Novikova SN; Sykalo NV; Potapenko RI; Mozzhukhina TG; Bogatskaia LN; Burchinskaia MK Patol Fiziol Eksp Ter; 2000; (1):15-7. PubMed ID: 10741181 [TBL] [Abstract][Full Text] [Related]
5. Insoluble lipoproteins in the pathogenesis of experimentally induced atherosclerosis. Waters LL Arch Pathol; 1972 Jun; 93(6):525-9. PubMed ID: 5025034 [No Abstract] [Full Text] [Related]
6. Are immunological mechanisms relevant for the development of atherosclerosis? Witztum JL; Palinski W Clin Immunol; 1999 Feb; 90(2):153-6. PubMed ID: 10080825 [No Abstract] [Full Text] [Related]
7. [Modified lipoproteins--their types and role in atherogenesis]. Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865 [TBL] [Abstract][Full Text] [Related]
8. [The comparative characteristics of the antiatherogenic effect of xymedon and parmidine]. Kamburg RA; Ibragimov OB; Kondrat'eva MB; Valeeva IKh; Shamsutdinov NSh Biull Eksp Biol Med; 1993 Aug; 116(8):205-8. PubMed ID: 8274706 [TBL] [Abstract][Full Text] [Related]
9. Renin as a risk factor for atherogenesis. Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one clip hypertension in the rabbit. Overturf ML; Sybers HD; Druilhet RE; Kirkendall WM Atherosclerosis; 1982 Apr; 42(2-3):141-60. PubMed ID: 7041917 [No Abstract] [Full Text] [Related]
10. [The role of a systemic inflammatory process in the atherogenic modification of lipoproteins and the development of hypercholesterolemia]. Bratus' VV; Talaieva TV; Radalovs'ka NV; Tretiak IV Fiziol Zh (1994); 1999; 45(1-2):40-9. PubMed ID: 10202635 [TBL] [Abstract][Full Text] [Related]
11. [Atherosclerosis, hypertension and age (an experimental study)]. Gorev NN; Cherkasskiĭ LP; Kozhura IM; Kozhura IP; Kopylova GV Vestn Akad Med Nauk SSSR; 1984; (3):16-20. PubMed ID: 6720054 [No Abstract] [Full Text] [Related]
12. [Endothelium, lipids and atherosclerosis]. Jorge PA Arq Bras Cardiol; 1997 Feb; 68(2):129-34. PubMed ID: 9433841 [No Abstract] [Full Text] [Related]
13. [The effect of fresh and dried vegetables on the development of experimental hypercholesterolemia and atherosclerosis in rabbits]. Kaĭdin DA; Klement'eva IV; Grebennik LI Farmakol Toksikol; 1966; 29(1):110-3. PubMed ID: 5988608 [No Abstract] [Full Text] [Related]
15. [The influence of physical activity on the development of experimental hypercholesteremia and atherosclerosis in rabbits]. Bobek P; Ginter E; Csörey K; Babala J Vnitr Lek; 1966 Apr; 12(4):323-32. PubMed ID: 5913528 [No Abstract] [Full Text] [Related]
16. [Classification of hyperlipoproteinemias and the problem of "atherogenicity"]. Fasoli A G Ital Cardiol; 1971; 1(4):287-90. PubMed ID: 5126211 [No Abstract] [Full Text] [Related]
17. Genetic basis of atherosclerosis: part I: new genes and pathways. Lusis AJ; Fogelman AM; Fonarow GC Circulation; 2004 Sep; 110(13):1868-73. PubMed ID: 15451808 [No Abstract] [Full Text] [Related]
18. [Atherosclerosis: role of cholesterol]. Feo F Minerva Med; 1978 May; 69(22):1527-30. PubMed ID: 210427 [No Abstract] [Full Text] [Related]
19. [Lipoproteins and the etiopathogenesis of atherosclerosis]. Dargel R Zentralbl Allg Pathol; 1989; 135(6):501-4. PubMed ID: 2683496 [TBL] [Abstract][Full Text] [Related]